Loading provider…
Loading provider…
Hematology & Oncology Physician in Chattanooga, TN
NPI: 1326096231Primary Practice Location
ERLANGER MEDICAL CENTER
910 Blackford St, Chattanooga, TN
Primary Employer
Tennessee Oncology - Nashville St Thomas Midtown
tnoncology.com
HQ Phone
Get MD Brooke's Phone Numberphone_androidMobile
Get MD Brooke's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
GA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 430 | 1,128 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 422 | 1,299 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 419 | 1,121 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 301 | 689 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 171 | 200 |
Authors: Howard Burris, Yuval Naot, John Zubkus
Journal: Clin Breast Cancer
Authors: John Hainsworth, Davey Daniel, John Zubkus
Journal: Clin Breast Cancer
Publication Date: 2014-10-02
Authors: Robyn Young, John Hainsworth, Jeffrey Bubis, William Harwin, Mark Keaton, Caryn Silver, Sharon Goble, Linda Bosserman, Kelly Pendergrass, David Drosick, Edward Arrowsmith, Yvonne Manalo, Donald Gravenor, Gladys Rodriguez, Roger Inhorn
Journal: Breast Cancer Res Treat
Publication Date: 2017-05-15
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: placebo, DRUG: nab-paclitaxel, DRUG: alpelisib
Lead Sponsor: Ambrx, Inc.
Intervention / Treatment: DRUG: ARX788
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Carboplatin, DRUG: Gemcitabine, DRUG: Trilaciclib